LIA
SCLN

LS Investment Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

LS Investment Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,720
Closed -$154K – 1914
2017
Q3 		$154K Buy
13,720
+3,517
+34% +$38.8K 0.01% 1039
2017
Q2 		$112K Sell
10,203
-117
-1% -$1.17K 0.01% 1102
2017
Q1 		$101K Buy
10,320
+8,355
+425% +$83.4K 0.01% 1117
2016
Q4 		$21K Hold
1,965
– – ﹤0.01% 1544
2016
Q3 		$20K Hold
1,965
– – ﹤0.01% 1528
2016
Q2 		$26K Buy
+1,965
New +$25.7K ﹤0.01% 1437

LS Investment Advisors's SCLN Position: Q4 2017 in Review

LS Investment Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 13,720 shares — an estimated $154K sold.

LS Investment Advisors first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $154K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • LS Investment Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • LS Investment Advisors sold 13,720 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $154K.
  • LS Investment Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • LS Investment Advisors's Sciclone Pharmaceuticals Inc position peaked at $154K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on LS Investment Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.